---
title: February Newsletter
---

We're thrilled to announce that two of LiVDerm's CME activities - Hidradenitis Suppurativa Clinician-Patient Summit and Atopic Dermatitis...

| View in browser FEBRUARY 2024 We're thrilled to announce that two of LiVDerm's CME activities - Hidradenitis Suppurativa Clinician-Patient Summit and Atopic Dermatitis: The Biggest Help for the Smallest Patients - have earned spots on the 2023 myCME Top Activities list based on high engagement and completions.    This speaks to the value of the clinically-focused curriculum handpicked by specialist faculty and the interactive case-based format resonating with learners. With months still remaining before expiration, we anticipate even greater knowledge gains and are proud to deliver acclaimed education addressing unmet needs. Congratulations to the experts and teams involved in developing and disseminating these impactful CME offerings!   Head over to LiVDerm’s CME Education Lab where you can access all of our complimentary activities designed to enhance your knowledge and expertise on a variety of relevant topics.  Access all of our complimentary activities SBS & MOPD: One Week to Go The South Beach Symposium (SBS) and Masters of Pediatric Dermatology Symposium (MOPD) kick off next week in Miami Beach!    That means, if you have not yet registered, this is your absolute last chance to do so and join us for the most highly anticipated medical and aesthetic dermatology event of the year.  The wait is nearly over - it's almost time for dermatology's premier annual events, the South Beach Symposium and the Masters of Pediatric Dermatology Symposium! Taking place February 8-11, 2024 in stunning Miami Beach, these renowned conferences will deliver cutting-edge insights through engaging presentations, lectures, and live demonstrations. Spaces are filling fast so secure your spot today to join top global experts across clinical, cosmetic, and pediatric dermatology. Whether participating for the first or fourteenth time, prepare for four days of transformative education alongside unparalleled networking!  Let the countdown begin! Industry News Galderma Announces Positive Results from their Phase 3 Study of RelabotulinumtoxinA Study Demonstrates Efficacy of Topical PF-07038124 in Treating Atopic Dermatitis and Plaque Psoriasis ZELSUVMI is First Prescription Medication for At-home Use In Treating Molluscum Contagiosum FDA Approves FILSUVEZ (birch triterpenes) for Epidermolysis Bullosa LiVDerm, 1801 North Military Trail, Suite 110, Boca Raton, FL 33431-1810, United States, 561-893-8625 Unsubscribe Manage preferences |
| --- |